SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q1 2022$1,101,000
-14.8%
91,6230.0%0.02%
-38.2%
Q4 2021$1,292,000
-5.2%
91,623
-31.3%
0.03%
+36.0%
Q3 2021$1,363,000
+32.5%
133,341
+245.2%
0.02%
+31.6%
Q2 2021$1,029,000
-39.7%
38,622
-16.0%
0.02%
-38.7%
Q4 2020$1,706,000
-22.1%
45,990
-13.7%
0.03%
-52.3%
Q3 2020$2,191,000
+183.1%
53,290
+179.0%
0.06%
+75.7%
Q2 2020$774,00019,1000.04%
Other shareholders
FIBROGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders